COMMUNIQUÉS West-GlobeNewswire

TRHC’s Capstone Performance System Continues Growth
01/10/2018
All Service Lines Won New Contracts or Expanded Services to Existing Clients ST. LOUIS and MOORESTOWN, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology [...]
Neon Therapeutics Congratulates Founder James P. Allison, Ph.D., for 2018 Nobel Prize in Physiology or Medicine
01/10/2018
Award Recognizes Achievements in Cancer Immunotherapy CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based [...]
Wildflower Signs MOU to Enter LA Delivery Market
01/10/2018
VANCOUVER, British Columbia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), is excited to announce that they have received a Memorandum of Understanding (MOU) with [...]
Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference
01/10/2018
BOSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
UPDATE: Nephros Announces Preliminary Financial Results for Third Quarter 2018
01/10/2018
Anticipates 102% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage [...]
Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff
01/10/2018
LAVAL, Québec, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. This transaction will support Altasciences’ goal [...]
Altasciences complète l’acquisition des activités d’essais précliniques et embauche du personnel clé
01/10/2018
LAVAL, Québec, 01 oct. 2018 (GLOBE NEWSWIRE) -- Altasciences a annoncé aujourd’hui l’acquisition des activités d’essais précliniques d’une installation située à Everett, dans l’État de Washington. Cette transaction s’ [...]
Cantabio Pharmaceuticals to Present Latest Positive In Vivo Results From its DJ-1 Targeting Small Molecule Drug Development Program for Parkinson’s Disease at the Milner Therapeutics Symposium at the University of Cambridge, UK
01/10/2018
SAN FRANCISCO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's (AD), Parkinson's (PD) and other [...]
Nova Leap Health Corp. Completes Purchase of Third Massachusetts Home Care Business
01/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
Cleveland Area Hospital Selects Cerner for Improved Rural Patient Care
01/10/2018
CLEVELAND, Okla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Cleveland Area Hospital has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue cycle [...]
Editas Medicine Grows Scientific Leadership with Two New Appointments
01/10/2018
CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that Richard A. Morgan, Ph.D., a leading expert in gene therapy and oncology, [...]
Advantis Corp Set to Debut Proprietary Sublingual Delivery System, Edible Orders Ramp Up Quickly
01/10/2018
NEWPORT BEACH, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - ADVANTIS CORPORATION (OTC PINK: ADVT) provided additional details about its sublingual tabs today, and revealed a proprietary process for med [...]
Medibio Named Finalist for Prestigious Optus My Business Award
01/10/2018
The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators MINNEAPOLIS, Minn. and SYDNEY, Australia, Oct. 01, 2018 ( [...]
Diversicare and Omega Enter Into a New Master Lease Agreement
01/10/2018
BRENTWOOD, Tenn., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced that pursuant to the binding agreement between [...]
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
01/10/2018
CALGARY, Alberta, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a scientific article in the [...]
Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast
01/10/2018
PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pressure BioSciences Inc. (OTCQB: PBIO ) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform [...]
CO2 GRO Announces 74% Increased Commercial Cannabis Bud Value
01/10/2018
Results of Third Dissolved CO2 Foliar Spray Cannabis Trial Demonstrates Continued Dramatic Increases in Value TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ” or the “ Company ”) (TSX-V: [...]
Vilacto Bio Announces Launch of Carmen Electra by Vilact®
01/10/2018
COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact , based on the company’s LACTOACTIVE® compound. LACTOACTIVE® is the [...]
Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference
01/10/2018
RALEIGH, N.C., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]

Pages